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Edited by Robert B. RussellAbstract Calcineurin (CaN) assists T-cell activation, growth
and diﬀerentiation of skeletal and cardiac myocytes, memory,
and apoptosis. It also activates transcription of the nuclear fac-
tor of activated T-cells (NFAT) family including hypertrophic
target genes. It has been reported that the modulatory calcineu-
rin-interacting protein (MCIP) inhibits the CaN activity and
thereby reduces the hypertrophic response. However, it has been
shown that MCIP facilitates or permits the hypertrophic re-
sponse under some stress conditions such as isoproterenol infu-
sion or pressure overload by transverse aortic constriction. As
there is no direct experimental evidence that can explain these
paradoxical phenomena, there has been a controversy concerning
the functional role of MCIP in developing the hypertrophic re-
sponse. It is therefore crucial to establish a hypothesis that can
clearly explain these phenomena. Towards this end, we propose
in this paper a hypothesis that is based on available experimental
evidence as well as mathematical modeling and computer simula-
tions. We hypothesize that there is a threshold in the nuclear
NFAT concentration above which MCIP is switched on. Below
this threshold, the inhibition of active CaN by MCIP is negligi-
ble, while the activated protein kinase increases the dissociation
rate of the CaN/MCIP complex. This leads to an augmentation
of active CaN. This mechanism realizes the positive eﬀect (i.e.,
removing any negative feedback) of MCIP in the hypertrophic
response. On the other hand, the over-expression of active
CaN increases nuclear NFAT to values above the threshold,
while CaN is inhibited through binding of MCIP (expressed by
the nuclear NFAT). This mechanism realizes the introduction
of a negative feedback mechanism. To unravel this switching
feedback mechanism, we have developed a mathematical modelAbbreviations: MCIP, modulatory calcineurin-interacting protein; PO,
pressure overload; ISO, isoproterenol; TAC, transverse aortic con-
striction; NFAT, nuclear factor of activated T-cells; NFATcyt, cyto-
plasmic dephosphorylated NFAT; NFAT
p
cyt, phosphorylated
NFATcyt; NFATnuc, nuclear NFAT; CaN, calcineurin; CnA, calci-
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lar conditions.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Keywords: CaN-NFAT signaling pathway; MCIP;
Dual role; Cardiac hypertrophy; Negative feedback;
Switching mechanism; Mathematical modeling;
Computer simulations; Dynamical analysis1. Introduction
Calcineurin (CaN) is related to many physiological processes
including T-cell activation, apoptosis, skeletal myocyte diﬀer-
entiation, and cardiac hypertrophy [1,12,17]. CaN enzyme is
a heterodimer composed of calcineurin catalytic A subunit
(CnA) and calcineurin regulatory B subunit (CnB). Its activity
is suppressed through binding of C-terminal domain of CnA
and autoinhibitory domain (AID) of the catalytic site at low
Ca2+ concentration; however, as Ca2+ concentration increases,
the protein phosphatase activity of CaN is induced by binding
of Ca2+-bound calmodulin (CaM) since CaM binding
displaces AID. There are three types of mammalian modula-
tory calcineurin-interacting protein (MCIP) genes: MCIP1,
MCIP2, and MCIP3 [1]. Among these, MCIP1 and MCIP2
are predominant in cardiac myocytes, and only MCIP1 is acti-
vated by the active CaN (CaN*) [3,4]. MCIP2 is activated by
thyroid hormone [3,4]. So, among the MCIP family, MCIP1
is the unique endogenous inhibitor of CaN and a well-con-
served negative feedback loop component ranging from yeast
to mammals [4,5]. In this respect, we focus only on MCIP1
among the MCIP family and simply use ‘MCIP’ instead of
‘MCIP1’ throughout the remaining part of this paper. MCIP
binds with CnA and thereby inhibits the phosphatase activity
of CaN. Intriguingly, some recent experiments have shown
that MCIP can also facilitate or permit the CaN activity under
some stress conditions such as isoproterenol (ISO) infusion or
pressure overload (PO) by transverse aortic constriction (TAC)
[2,6]. Such a role change of MCIP provides a good reason to
consider it as a therapeutic target in cardiac hypertrophyblished by Elsevier B.V. All rights reserved.
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CaN signaling pathway receives a more attention than ever,
the unknown underlying mechanism that realizes the dual role
(role change) of MCIP in the CaN signaling pathway contin-
ues to pose important questions.
In this paper, we investigate available experimental results
related to the controversy on the role of MCIP and based on
this information develop a hypothesis that can explain the
changing role of MCIP in the development of cardiac hyper-
trophy. In particular, we hypothesize that there is a threshold
in the nuclear factor of activated T-cells (NFAT) concentra-
tion above which MCIP is switched on. We consider two dif-
ferent stress conditions, PO (or ISO infusion) and CaN*(›)
(over-expression of the active CaN expressed from a muscle
speciﬁc transgene). Under the stress condition of PO, the con-
centration of nuclear NFAT (NFATnuc) gets below the thresh-
old and therefore the inhibition of CaN* by MCIP should be
negligible; however, the release of CaN from the CaN/MCIP
complex by some protein kinase (PK) increases CaN* so that
NFATnuc gets increased and incurs a hypertrophic response.
This mechanism realizes the positive eﬀect of MCIP in the
development of cardiac hypertrophy by switching oﬀ the neg-
ative feedback. On the other hand, under the stress condition
of CaN*(›), NFATnuc gets above the threshold and therefore
CaN* becomes inhibited by MCIP expressed from NFATnuc.
This inhibitory mechanism realizes the negative eﬀect of MCIP
by switching on the negative feedback. So, the functional role
change of MCIP can be explained by this switching feedback
mechanism. We present a mathematical model of the CaN-
NFAT signaling pathway and quantitatively analyze the
underlying dynamics and regulatory mechanism on the role
change of MCIP through computer simulations. The simula-
tion results are in agreement with existing experimental data
and serve as an explaination for the role change of MCIP
under diﬀerent stress conditions.Table 1
Hypertrophic response to diﬀerent stress stimuli
Stress
condition
Mutation Heart size compared
with a wild-type
littermate
Experimental
number
No stress MCIP+/+ No change Control
PO, ISO
Infusion
MCIP/ Slight increase EXP 2, EXP 4
MCIP+/+ Increase
CaN*(›) MCIP/ Severe increase EXP 1, EXP 3
MCIP+/+ Increase
The hypertrophic response is graded as ‘no change’, ‘slight increase’,
‘increase’, and ‘severe increase’ according to the order of HW/BW.2. Materials and methods
2.1. Experimental evidences on the functional role of MCIP
There has been a controversy about the functional role of MCIP in
the development of cardiac hypertrophy caused by a series of recent
experiments [2,5–7]. These experiments identiﬁed the role changing
phenomena of MCIP under diﬀerent stress conditions. We revisit pre-
vious experimental results and analyze their implications in order to
infer a hypothesis that can explain the hidden mechanism of such
paradoxical change of roles for MCIP.
Vega et al. [2] and Sanna et al. [6] showed that the hypertophic
response to CaN* over-expression was exacerbated in the MCIP/
background (we refer to this experimental result asEXP1 later on).Vega
et al. showed that the increase of HW/BW (heart weight normalized to
bodyweight) ratios caused byCnA*(›) was larger in theMCIP1/ ani-
mals than in the wild-type littermates (49% increase in CnA*(›) vs. 26%
in WT). Sanna et al. more clearly showed Vega’s experimental results:
the transgenic over-expression of the active CaN induced nearly 130%
increase of heart weight normalized to tibia length (HW/TL) ratios in
MCIP1/ mice but nearly 70% increase in the wild type littermates.
These experimental results suggest that MCIP suppresses the hypertro-
phic response under the stress condition of CaN*(›). Vega et al. [2] also
showed that theMCIP1/ animals exhibited a smaller degree of hyper-
trophy than wild-type controls in the PO model by TAC (referred to as
EXP 2 later on). The left ventricular weight normalized to body weight
(LVW/BW) ratios increased to 16% and 29% in TAC animals and wild-
type controls, respectively. Sanna et al. observed similar phenomena
from 2KO mice (MCIP1/ and MCIP2/): the HW/LT ratios of
TAC animals were increased by approximately 11% and 29% in 2KO
animals and wild-type controls, respectively. In addition, Vega et al.[2] demonstrated that MICP1/ mice diminished the hypertrophic
response to ISO (a b-adrenergic agonist) compared with wild-type con-
trols (16% vs. 41% increase in LVW/BW). These experimental results
suggest that MCIP facilitates or permits a hyopertrophic response un-
der the stress conditions, PO and ISO infusion. Rothermel et al. [7]
showed that the cardiac speciﬁc MCIP1 TG mice attenuated the extent
of hypertrophic growth induced by CaN*(›) (referred to as EXP 3 later
on). They observed massive cardiac hypertrophy in CaN* TG mice, in
which the HW/BW ratios were increased by nearly 130%. However, the
cardiac hypertrophic response to a concomitant expression of the
MCIP1 transgene attenuated the HW/BW ratios to 31%. These exper-
imental results suggest that MCIP(›) (cardiac speciﬁc over-expression
of MCIP) signiﬁcantly suppresses the cardiac hypertrophic growth un-
der CaN*(›). Rothermel et al. [7] also showed that the MCIP1 TG
mice attenuated the cardiac hypertrophic response to either b-adrener-
gic receptor (b-AR) stimulation or exercise (referred to as EXP 4 later
on). ISO infusion produced a modest degree of cardiac hypertrophy in
male wild-type animals (22.8% increase in HW/BW). This hypertrophic
response became diminished by transgenic over-expression of MCIP1
(9.4% increase in HW/BW). Physiological adaptive hypertrophy after
28 days of nocturnal wheel running exercise was reduced in MCIP1
TG mice (29.2% in WT and 12.3% in TG). These experimental results
suggest that MCIP(›) suppresses the hypertrophic growth under stress
conditions such as PO or ISO infusion. Rothermel et al. [5] showed
that MCIP1 is capable of binding and inhibiting the catalytic subunit
of CaN (referred to as EXP 5 later on). Sanna et al. showed that PO
and phenylephrine (PE) plus angiotensin II (AngII) infusion did not
detectably increase MCIP1 protein levels in the heart (referred to as
EXP 6 later on). These results suggest that, although CaN is activated
by theses stimuli, it is not of suﬃcient magnitude to increase the
MCIP1 protein expression to inhibitory levels. Abbasi et al. [8] showed
that some protein kinase becomes activated under the stress condition
of AngII stimulation and then MCIP gets phosphorylated and released
from the CaN/MCIP complex (referred to as EXP 7 later on). Among
these experimental results, the hypertrophic responses (EXP 1–4) to
diﬀerent stimuli are summarized in Table 1. The change of the hyper-
trophic response (HW/BW) to diﬀerent stress stimuli is illustrated in
Fig. 1 where constitutive CaN* in TG is larger than that of PO or
ISO infusion [2,23]. We can suggest two functional roles of MCIP from
Fig. 1 as follows: the hypertrophic response in MCIP/ is smaller
than that in WT under PO or ISO infusion (‘positive eﬀect’), but this
response is larger than that in WT under CaN*(›) (‘negative eﬀect’).
The controversy on the diﬀerent functional roles of MCIP in the hyper-
trophic response was caused by these observations.
2.2. Mathematical modeling of the CaN-NFAT signaling pathway
We develop a mathematical model of the CaN-NFAT signaling
pathway, based on experimental evidence and analyze its dynamics
to unravel the mechanism responsible for change of the functional role
of MCIP. The detailed ordinary diﬀerential equations of the model are
described in Table 2. CaN is allosterically switched from a free state
([CaNfree]) to an active state ([CaNactive]) through Ca
2+/CaM binding
while it is deactivated through MCIP binding ([CaNcomp]). These state
transitions are described by Eqs. (1)–(3) in Table 2, where it is assumed
that the active protein kinase (c in Eq. (2)) sigmoidally increases along
with CaN* under stress conditions. CaN* ([CaNactive]) dephosrphory-
lates NFATpcytð½NFAT pcytÞ and NFATcyt ([NFATcyt]) translocates into
the nucleus to inﬂuence the transcription of hypertrophic genes, includ-
Fig. 1. Illustration of the hypertrophic response to diﬀerent stress
stimuli reported in the previous experiments [2,6]. The blue solid line
and the red dotted line represent the hypertrophic response of
MCIP1/ TG and the wild-type, respectively. (For interpretation
of the references in colour in this ﬁgure legend, the reader is referred to
the web version of this article.)
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gen synthase kinase-3b (GSK-3b), p38, and cAMP dependent protein
kinase A (PKA), represented by GPP ([GPP]), phosphorylate NFATcyt
and antagonizes CaN by stimulating the nuclear NFAT export show-
ing a potential antihypertrophic activity [16]. The regulatory relation-
ships of NFAT and GPP are described by Eqs. (4)–(6) in Table 2. The
expression of MCIP induced by NFATnuc ([NFATnuc]) is described by
Eq. (7) in Table 2. All the parameter values of the mathematical model
are summarized in Table 3.
To investigate the dynamics of the CaN-NFAT signaling pathway
and the underlying role change mechanism of MCIP under the diﬀer-
ent stress conditions, we have conducted extensive computer simula-
tions over a broad range of Ca2+ concentrations (10 nM to 1 lM) as
the Ca2+ levels represent diﬀerent stress conditions [19–21]. The range
of Ca2+ concentrations was chosen based on the experimental evidence
presented in [19–22]. For instance, the resting Ca2+ concentration of
cardiac myocytes is less than 0.2 lM under a normal condition, but
it becomes more than 0.7 lMunder a stress condition in mice, allowing
for some variations related to the species (e.g., rat, ferret, guinea pig,
canine, etc.). Throughout the simulations, we assumed a constantTable 2
The mathematical model of the CaN-NFAT signaling pathway
d½CaNfree
dt
¼ ka1  ½CaNfree  ½Ca2þ þ kd1  ½CaNactive
d½CaNcomp
dt
¼ ka2  ½CaNactive  ½MCIP 
1þh2
kh2th þ ½MCIP h2
 kd2  c  ½CaNcomp where c ¼
k
½CaNtot ¼ ½CaNfree þ ½CaNactive þ ½CaNcomp
d½NFAT cyt 
dt
¼ kc1½NFAT
p
cyt½CaNactiveh1
kh1m1 þ ½CaNactiveh1
 ðlctu þ kr1Þ  ½NFAT cyt þ lutc½NFAT nuc
d½NFAT nuc
dt
¼ lctu½NFAT cyt  lutc½NFAT nuc  kc2½GPP ½NFAT nuckm2 þ ½NFAT nuc
½NFAT tot ¼ ½NFAT pcyt þ ½NFAT cyt  þ ½NFAT nuc
d½MCIP 
dt
¼ v1f½NFAT nuc þ cof g
h
khnuc þ f½NFAT nuc þ cof gh
 ka2½CaNactive ½MCIP 
1þh2
kh2th þ ½MCIP h2
þ kd2  c 
Note that the protein kinases GSK-3b, p38, and PKA that phospholate NFCa2+ concentration since CaN responds to sustained, low frequency
Ca2+ [18].
Let us deﬁne a measure called area under curve (AUC) of NFATnuc
to quantify the hypertrophic response to Ca2+ stimulation as follows:
AUCðt;Ca2þÞ ¼
Z t
0
NFATnucðs; Ca2þÞds
In the simulations, we cover an interval to t = 20 h since NFATnuc
reaches its steady-state value after about 20 h, under diﬀerent Ca2+
stimulations (Fig. 6). The equations in Table 2 were solved using the
Runge–Kutta–Merson numerical integration algorithm with Matlab
7.1 (R14) on an HP workstation xw6000.3. Results
In this section, we present a hypothesis on the role changing
mechanism ofMCIP, based on the previously published experi-
mental results (EXP 1–7) and demonstrate the dynamical
characteristics of this mechanism under diﬀerent stress condi-
tions through computer simulations of the proposed mathe-
matical model.
3.1. The switching feedback mechanism under diﬀerent stress
conditions
The b-adrenergic signaling pathway is activated by a variety
of stress stimuli including PO and b-AR agonist. If then, the
intracellular Ca2+ becomes increased by the downstream pro-
teins such as PKA and Ca2+/calmodulin dependent protein
kinase II (CaMKII); CaN is activated by Ca2+ bound CaM.
Finally, NFAT is dephosphorylated by CaN* and then trans-
locates into the nucleus. It eventually induces the transcription
of a variety of genes involved in the response of cardiac hyper-
trophy [2,9,10]. It has been assumed that the hypertrophic
response gets enhanced along with the concentration of CaN*
[2,6,23]. Since MCIP/ mice exhibited no overt phonotype
in the absence of stress [2], we presume that the concentration
of CaN* in MCIP/ mice is almost same as that of WT.ð1Þ
½CaNactiveh1
h1
m3 þ ½CaNactiveh1
ð2Þ
ð3Þ
ð4Þ
ð5Þ
ð6Þ
½CaNcomp  kdeg½MCIP  ð7Þ
ATcyt in Fig. 2 are represented by GPP in the equations.
Table 3
Parameters of the mathematical model used for simulations
Parameter Value Unit Description
ka1 0.3 lM
1 min1 Association rate constant of Ca2+ and CaN
kd1 0.08 min
1 Dissociation rate constant from the Ca2+/CaN complex [13]
ka2 8.53 lM
1 min1 Association rate constant of CaN and MCIP
kd2 5.67e2 min1 Dissociation rate constant from the CaN/MCIP complex
kc1 2 lM
1 min1 Dephosphorylation rate constant of NFAT by CaN* [13]
km1 0.4 lM Half maximal concentration of CaN
kc2 4.5e4 lM1 min1 NFAT phosphorylation rate constant of GPP
km2 0.01 lM Half maximal concentration of GPP
v1 0.02 min
1 MCIP expression rate constant [13]
knuc 0.03 lM Half maximal concentration of NFATnuc
lctu 5.4e3 min1 Import rate constant of NFAT from cytoplasm to nucleus
lutc 4.8e4 min1 Export rate constant of NFAT from nucleus to cytoplasm [14]
km3 0.001 lM Half maximal concentration of active CaN
kr1 0.005 min
1 Constitutive phosphorylation rate of NFAT
kdeg 0.1 min
1 Degradation rate of MCIP
h 17 – Hill coeﬃcient
h1 5 – Hill coeﬃcient
h2 15 – Hill coeﬃcient
cof 0.025 lM Cofactor for NFAT transcription
kth 0.037 lM Threshold value of NFATnuc
GPP 0.01 lM Concentration of GPP
CaNtot 1.0 lM Total concentration of CaN [15]
NFATtot 0.017 lM Total concentration of NFAT [13]
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experimental results under diﬀerent stress stimuli which alters
the concentration of CaN* in MCIP/ mice and WT. The
hypertrophic response under PO or ISO infusion occurs more
signiﬁcantly in WT than in MCIP/ mice [EXP 2]. The MAP
kinase signaling pathway is triggered by the activated b-AR
and epidermal growth factor receptor (EGFR) [6,11] and then
its downstream signaling proteins such as mitogen-activated
protein kinase kinase 5 (MEK5) and big mitogen-activated
protein kinase 1 (BMK1) are activated. These protein kinases
induce the phosphorylation of MCIP and thereby CaN is
released from the CaN/MCIP complex [EXP 7]. MCIP in WT
is, however, not increased enough to suppress the activity of
CaN in response to PO or ISO infusion [EXP 6]. So, we infer
that the concentration of NFATnuc under PO or ISO infusion
is not suﬃciently increased to induce MCIP. On the other
hand, MCIP inhibits the activity of CaN through binding with
its catalytic domain in vivo and in vitro [EXP 5]. Under the
stress condition of CaN*(›), the hypertrophic response gets
blunt in WT compared to that of MCIP/ mice [EXP 1].
These imply that NFATnuc under this stress condition in-
creases MCIP such that it suppresses CaN*. Thus, we infer
that there is a threshold in the concentration of NFATnuc by
which MCIP is turned on or oﬀ depending on the stress condi-
tions. By integrating these inferences, we propose a hypothesis
on the role changing mechanism of MCIP as follows: under
PO or ISO infusion, the expression of MCIP is negligible since
the concentration of NFATnuc is below the threshold and
therefore CaN* is hardly inhibited by MCIP. In addition, the
dissociation of the CaN/MCIP complex becomes accelerated
by the activated protein kinase and this increases CaN* leading
to a hypertrophic response. Hence, this mechanism realizes the
positive eﬀect (i.e., switching oﬀ the negative feedback) of
MCIP in the hypertrophic response. On the other hand, under
CaN*(›) condition, NFATnuc gets increased above the thresh-
old and this makes CaN* signiﬁcantly inhibited by MCIP.
Thus, this feedback mechanism realizes the negative eﬀect(i.e., switching on the negative feedback) of MCIP. Although
CaN can be released from the CaN/MCIP complex by the pro-
tein kinase, the amount is negligible compared to that inhibited
by MCIP. In summary, we conclude that the switching feed-
back mechanism of the negative feedback loop realizes the
dual role of MCIP in the regulation of the CaN activity (see
Fig. 2).3.2. The simulation results
The system responses under two typical stress conditions are
shown in Fig. 3 (0.4 lM of Ca2+ for a strong stress condition)
and Fig. 4 (0.04 lM of Ca2+ for a mild stress condition). In
Figs. 3 and 4, the panels A and B and the panels C and D show
the system dynamics of WT and MCIP/, respectively.
Throughout this simulation study, we analyze the changing
feature of hypertrophic response and the underlying MCIP
regulatory mechanism given the typical stress conditions. In
WT mice under the strong stress condition (Fig. 3A and B),
it takes ca. 35 min after Ca2+ stimulation for CaN* to reach
its maximum value of 0.35 lM and then CaN* gets progres-
sively decreased to its steady-state value of 0.1 lM in 2.6 h
as shown in Fig. 3A. In the meanwhile, MCIP keeps a small
concentration level in the initial phase and gets increased after
2.4 h. MCIP reaches its maximum value of 0.154 lM in 3.7 h
(Fig. 3A). Hence, it turns out that MCIP eﬀectively suppresses
CaN* through the negative feedback mechanism under the
strong stress condition. On the other hand, NFATcyt gets in-
creased to its maximum value of 16 nM in 18 min as the in-
crease of CaN* in the initial phase induces the rapid decrease
of NFATpcyt (Fig. 3B). However, after 1.2 h, NFAT
p
cyt increases
since CaN* gets inhibited by MCIP and this induces the phos-
phorylation of NFATcyt; NFAT
p
cyt increases up to 12.8 nM in
9.3 h due to the sustained inhibition of CaN* by MCIP. Thus,
NFATcyt gradually decreases after 18 min and ﬁnally reaches
its minimum value in 7.5 h. In inverse proportion to NFATcyt,
NFATnuc increases to its maximum value of 7.27 nM in 3.25 h;
Fig. 2. A schematic diagram illustrating the CaN-NFAT signaling pathway and its regulatory mechanisms.
Fig. 3. Computational simulations of the CaN-NFAT signaling pathway under a strong stress condition (0.4 lM of Ca2+). The active CaN gets
much suppressed (A) and the nuclear NFAT is attenuated (B) as MCIP increases in WT. The active CaN and the nuclear NFAT monotonically
increase for MCIP/ (C and D).
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state value of 3.5 nM in 10 h. All these simulations are in
agreement with previously published experimental results and
provide a good rationale in understanding the functional role
of MCIP in Exp 1 and Exp 3 [2,6].
In MCIP/mice under the strong stress condition (Fig. 3C
and D), CaN* monotonically increases to the steady-statevalue of 0.3 lM in 32 min after Ca2+ stimulation (Fig. 3C).
Unlike CaN* in WT, CaN* in MCIP/ mice does not
decrease since the CaN inhibitor, MCIP is completely deleted.
On the other hand, NFATcyt rapidly increases to its maximum
value of 15.6 nM in 21 min due to the increase of CaN* in the
initial phase; however, NFATcyt gets gradually decreased to its
steady-state value of 5.5 nM which is larger than that of WT
Fig. 4. Computational simulations of the CaN-NFAT signaling pathway under a mild stress condition (0.04 lM of Ca2+). The active CaN in WT (A)
is larger than that of MCIP/ (C) and the nuclear NFAT in WT (B) is also larger than that of MCIP/ (D).
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WT. In inverse proportion to NFATcyt, NFATnuc increases
to its maximum value of 11.4 nM (Fig. 3D) which is 226%
larger than that of WT. From these simulation results, we
found that the hypertrophic response represented by NFATnuc
becomes more signiﬁcantly augmented in MCIP/ than in
WT under the strong stress condition, which is in agreement
with the experimental evidence presented in Exp 1 and Exp 3
[2,6].
In WT mice under the mild stress condition (Fig. 4A and B),
CaN* increases to its maximum value of 0.123 lM in 2.2 h after
Ca2+ stimulation and then progressively decreases (Fig. 4A).
This maximum CaN* is lower than that of the strong stress con-
dition in Fig. 3A. This is because Ca2+ stimulation increasesFig. 5. The AUC of nuclear NFAT according to the increase of Ca2+ stimula
MCIP1/ in (A) along with the initial CaN/MCIP complex concentration
results shown in Fig. 1.along with the strength of stress. The attenuation of CaN* by
MCIP is remarkably reduced since the expression of the CaN
inhibitor, MCIP is very small compared to that of the strong
stress condition. On the other hand, NFATcyt gets increased
to its maximum value of 5.15 nM in 2.8 h after Ca2+ stimula-
tion and then converges to its steady-state value of 1.61 nM
(Fig. 4B). However, the maximum value of NFATcyt is much
smaller and the rising time to the maximum value is also more
prolonged compared to those under the strong stress conditions
due to the reduced CaN*. Hence, NFATnuc is signiﬁcantly
attenuated with the 108% decreased maximum value
(3.49 nM in 5.32 h) compared to that of the strong stress condi-
tion (Fig. 4B). The rising time taken for NFATnuc to reach its
maximum value is prolonged by 64% compared to that of thetion in WT and MCIP/ (A), and the crossing point between WT and
(B). The AUC curves are in agreement with the previous experimental
Fig. 6. The response curves of NFAT (A) and MCIP (B) according to the increase of Ca2+ stimulation. The maximum response value becomes larger
and the response time taken to reach the maximum value gets shorter as Ca2+ increases.
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of MCIP induced by NFATnuc is signiﬁcantly suppressed under
the mild stress condition. This simulation result is in agreement
with EXP 6 [6] in that MCIP does not much increase under the
mild stress condition such as PO or ISO infusion.
In MCIP/ mice under the mild stress condition (Fig. 4C
and D), CaN* increases to its steady-state value of 65 nM
in 1 h after Ca2+ stimulation (Fig. 4C), but NFATcyc and
NFATnuc are little increased (Fig. 4D) since the total concen-
tration of CaN is decreased by 50% in MCIP/ compared
to that of WT.
Fig. 5A shows the AUC proﬁles according to the variation
of Ca2+ concentration in MCIP/ and WT models whereFig. 7. Illustration of the negative feedback dynamics with (A and C) or with
negative feedback loop does not make any diﬀerence in the outputs for a large
small input signal (S = 0.1) (C and D). The parameters and initial values used
km = 0 (B and D), km = 0.2 (A and C), x(0) = 0, and y(0) = 0. The blue so
interpretation of the references in colour in this ﬁgure legend, the reader is rthe initial concentration of the CaN/MCIP complex
([CaNcomp(0)]) is 0.5 lM. Note that the crossing point between
the two AUC curves of MCIP/ and WT in Fig. 5A delimits
the functional role of MCIP as follows: if Ca2+ < 0.08 lM,
MCIP has the positive eﬀect (i.e., switching oﬀ the negative
feedback) in that the hypertrophic response in WT is larger
than that of MCIP/; if Ca2+ P 0.08 lM, it has the nega-
tive eﬀect (i.e., switching on the negative feedback) in that
the hypertrophic response in WT is smaller than that of
MCIP/. The Ca2+ concentration at the crossing point gets
increased along with [CaNcomp(0)] (Fig. 5B). In particular,
above 0.5 lM, the crossing point increases in a non-linear
way. These results suggest that the negative eﬀect of MCIPout (B and D) the switching mechanism. The switching mechanism of a
input signal (S = 0.9) (A and B), but shows a signiﬁcant diﬀerence for a
for simulations are as follows: a = 0.4, g = 0.2, d = 0.25, b0 = 3, n = 5,
lid line and the red dashed line represent x and y, respectively. (For
eferred to the web version of this article.)
5972 S.-Y. Shin et al. / FEBS Letters 580 (2006) 5965–5973emerges at a higher Ca2+ concentration (for a stronger stress
condition) as [CaNcomp(0)] becomes larger. For instance, if
[CaNcomp (0)] = 0.5 lM, the negative eﬀect of MCIP emerges
at 0.09 lM Ca2+ while, if [CaNcomp(0)] = 0.7 lM, this negative
eﬀect emerges at 0.35 lM Ca2+. The dynamics of NFATnuc
and MCIP in WT under diﬀerent Ca2+ stimulations are shown
in Fig. 6 where the maximum values of NFATnuc and MCIP
increase and their rising time to reach the maximum values gets
shortened as Ca2+ increases.4. Discussion
In this paper, we have proposed a hypothesis explaining the
role change of MCIP realized by a switching feedback mecha-
nism in the CaN-NFAT signaling pathway. The development
of the mathematical model and the computer simulations have
revealed the dynamics of CaN-NFAT signaling pathway in a
quantitative way. We have also found that the initial concen-
tration of the CaN/MCIP complex is important in determining
the functional role of MCIP. Sanna et al. [6] did not agree with
the inhibitory eﬀect of MCIP reported by the over-expression
approach. Instead, they explained the inhibition as a sequestra-
tion eﬀect meaning that if kinase or phosphatase docking/acti-
vating proteins are over-expressed then they can intrinsically
have an inhibitory function. Contrary to this, we proposed a
hypothesis from a diﬀerent perspective, supported by experi-
mental evidence and quantitative analysis through mathemat-
ical modeling and simulations.
Let us consider the following simple example to further
investigate the dynamics of a feedback loop system with a
switching mechanism:
dx
dt
¼ S  a  x b  y;
dy
dt
¼ g  x d  y with b ¼ b0  y
n
knm þ yn
or b ¼ b0
where b0 y
n
knmþyn denotes a variable gain with the threshold of km, b0
is a constant gain, S is an input signal, and y is an output sig-
nal. Here, the switching feedback mechanism is realized by the
variable gain b0 y
n
knmþyn. If the input signal increases the output sig-
nal above the threshold km, the variable gain
b0 yn
knmþyn converges to
the constant gain b0; however, if the output signal remains
below km, the variable feedback gain gets signiﬁcantly attenu-
ated below b0. Fig. 7A and C and B and D shows the dynamics
of the negative feedback loop system with b ¼ b0 ynknmþyn and that
with b = b0, respectively. For a relatively high input signal
(S = 0.9), the maximal output with the variable gain is about
35% larger than that with the constant gain; however, for a rel-
atively low input signal (S = 0.1), the maximal output with the
variable gain is about 130% larger than that with the constant
gain. Therefore, the switching feedback mechanism plays an
important role in the cut-oﬀ eﬀect of a negative feedback loop
system for a low input signal. In intracellular signaling sys-
tems, the switching feedback mechanism may serve to keep
homeostasis or a constant equilibrium of the cellular system
from excessive external stimuli and to adapt to other allowable
stimuli.
The present paper described the functional role of MCIP in
the regulation of the CaN-NFAT signaling pathway. The pre-
sented results may provide fundamental information to thedevelopment of anti-hypertrophic drug agents interfering with
the CaN-NFAT signaling pathway or immuno-suppressive
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